Certain commonly used sleeping pills will now contain a new boxed warning alerting patients to possible serious or life-threatening behaviors that may result from taking these drugs, the FDA says
Certain commonly used sleeping pills will now contain a new boxed warning alerting patients to possible serious or life-threatening behaviors that may result from taking these drugs, the US Food and Drug Administration announced Tuesday. The move follows several reports of rare but serious injuries and deaths resulting from sleepwalking, sleep-driving and other complex behaviors while sleeping, such as unsafe use of a stove.
Eszopiclone , zaleplon and zolpidem will require the new boxed warnings, which are the most prominent of FDA cautions, the agency said.Mark Zuckerberg says he invented a 'sleep box' to improve his wife's slumber"These incidents can occur after the first dose of these sleep medicines or after a longer period of treatment, and can occur in patients without any history of these behaviors and even at the lowest recommended doses," Acting Commissioner Dr.
All patients should be notified about possible"morning after" risks, the FDA said at the time.Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said Tuesday that the agency has monitored these drugs since they were approved: eszopiclone was approved in 2004, zaleplon in 1999 and zolpidem in 1992.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA found harmful pathogens at 21 percent of ice cream plants it testedThe FDA detected harmful pathogens at 21 percent of ice cream production facilities inspected during a yearlong assessment
Lire la suite »
Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis treatmentBausch Health, formerly known as Valeant Pharmaceuticals, said Thursday that it and its dermatology business, Ortho Dermatologics received approval from the FDA for a lotion to treat plaque psoriasis.
Lire la suite »
FDA expands blood pressure drug recall for fifth time this yearNot all versions of the widely used medications are contaminated, but ongoing recalls may cause shortages, an FDA spokesperson said.
Lire la suite »
Parents cautious of new FDA-approved device for kids with ADHDFDA’s approval of the first medical device of its kind to treat ADHD in children s being met with 'cautious optimism' by parents and advocates.
Lire la suite »
FDA investigation finds some ice cream makers in 'violation of the law'The FDA says it inspected and obtained samples from 89 ice cream production facilities in 32 states in 2016 and 2017, detecting listeria monocytogenes, which can cause listeriosis, at 19 facilities and one instance of salmonella
Lire la suite »
Amid FDA Crackdown, Walgreens Will Raise Age To 21 For Tobacco PurchasesWalgreens will require tobacco purchasers to be at least 21 years old effective Sept. 1 of this year in a move to prevent young people from purchasing cigarettes and related tobacco products.
Lire la suite »
The FDA Says It’s Safe, So Feel Free to Say ‘Yes’ to MSGJapan’s Ajinomoto is in the middle of a campaign to persuade Americans that the seasoning it has made for more than a century is safe--and maybe even good for you.
Lire la suite »
FDA Approves Philip Morris International Heat-Not-Burn IQOS Device for Sale in U.S.The Food and Drug Administration said it would allow two of the world’s biggest cigarette makers to start selling in the U.S. a hand-held device that heats but doesn’t burn tobacco.
Lire la suite »